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Abstract 
Background: Antimicrobial stewardship (AMS) is a key strategy promoting rational antimicrobial use. 
In Zambia, information on health professionals’ knowledge, attitude, and practice of AMS is limited. 
This study was undertaken to address this at Zambia’s leading specialised teaching hospitals. 
Methods: Descriptive, cross-sectional study involving 137 physicians and 61 pharmacists. Results: 
AMS knowledge was relatively low among physicians (51%) and pharmacists (39%). Few physicians 
(9%) and pharmacists (20%) demonstrated sufficient knowledge of the basic principles of AMS. 
Physicians’ and pharmacists’ knowledge levels were significantly associated with years of practice, 
job position or practice rank, and previous AMS training. The majority (95%) perceived AMR as a 
current problem in their practise. Most physicians (92%) and pharmacists (86%) had not undertaken 
AMS training before. All indicated the need for context-specific educational interventions to promote 
AMS in Zambia. Conclusion: Despite positive perceptions, basic knowledge of AMS was relatively 
low. Context-specific educational interventions and capacity building are needed to address AMS 
gaps.  
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Introduction 
Antimicrobial resistance (AMR) is a major public health concern increasing morbidity, mortality, and 
costs (1-5). The increasing inappropriate use of antibiotics driving AMR has led to international, 
regional and national initiatives to address this concern (6-10). AMR is one of the most important 
challenges facing healthcare systems worldwide (4, 6, 11, 12). If left unattended, an estimated 10 to 
444 million people will die annually from AMR by 2050, appreciably reducing gross domestic product 
(GDP) among countries (3, 4, 10). Inappropriate use of antibiotics includes their inappropriate 
prescribing and dispensing (13-16). In low and middle-income countries (LMICs), antimicrobial use is 
increasing, yet in many cases antibiotic use is inappropriate or suboptimal, enhanced by the lack of 
adequate surveillance systems and governance (9, 12, 17-22). In addition, there is considerable self-
purchasing of antibiotics among patients in LMICs often for viral infections such as upper respiratory 
tract infections (16, 23-27).  
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AMR poses a particular health risk in LMICs compared to higher income countries due to the double 
burden of communicable and non-communicable diseases (10, 28-30), including increased risk of life-
threatening infectious diseases such as HIV, tuberculosis, pneumonia, and malaria (31-33). 
Consequently, it is imperative to improve the prescribing and dispensing of antimicrobials in LMICs.  
The instigation of antimicrobial stewardship (AMS) at health service delivery points particularly in 
hospitals is a recognised strategy to improve antimicrobial use and arrest growing AMR rates (34-39). 
However, recognising that AMS programmes are particularly challenging in LMICs due to health 
structure issues as well as lack of implementation of policies (40). AMS programmes though enable 
coordinated interventions designed to improve and measure appropriate use of antimicrobials through 
formulary development, promoting the optimal selection of antimicrobial drug regimens and their 
treatment duration, as well as promoting optimal routes of administration. AMS programmes are also 
known to improve the quality of patient care by reducing adverse events and improving patient 
outcomes (35, 37, 40). In addition, AMS programmes reduce AMR and the spread of infections 
caused by multidrug-resistant organisms (41). Already in 2003, Carling and colleagues (42) have 
documented the benefits of good AMS in hospital settings whereby a well implemented 
multidisciplinary AMS programme consistently demonstrated a decrease in the incidence of 
Clostridioides difficile–associated diarrhoea. Studies have also promoted key stakeholder groups in 
LMICs such as pharmacists to develop guidelines for AMS programmes (43) to improve subsequent 
antimicrobial use, especially in hospitals. 
 
In Zambia, high rates of irrational antimicrobial prescribing and dispensing have been reported (44), 
with most antibiotics prescribed in hospitals without bacteriological tests (45) similar to a number of 
other LMICs (46-50).  There are also high rates of self-purchasing of antibiotics without prescription in 
Zambia adding to AMR rates (24). However, to develop and provide potential initiatives to address 
irrational antimicrobial use in Zambia, there is a need to identify and address knowledge gaps 
including practice and behaviours of healthcare providers, which may be driving up AMR rates (51). 
We are aware through previous research by other scholars that there is variable knowledge of 
antibiotics and AMR among key stakeholder groups including physicians and pharmacists (52-63), 
with pharmacists typically being a member of AMS groups within hospitals (35, 64, 65). Lack of 
knowledge about antibiotic utilisation, AMR and AMS practice is a concern in the local setting. 
Knowledgeable physicians and pharmacists are crucial to the success of any AMS programme 
through developing and implementing appropriate antimicrobial strategies in their health facilities.  
Prior to this study, it was not known how existing knowledge of AMS and perceptions of AMR, or lack 
of it, could be influencing antimicrobial utilization in Zambia. This study was seen as important given 
the high burden of infectious diseases in Zambia including HIV/AIDS, tuberculosis, malaria, and 
pneumonia (24), as well as concerns about the lack of AMS programmes in a number of African 
countries (40, 66). Consequently, data on the existing knowledge and perceptions of AMS concepts 
among key health professionals was essential as a starting point to evaluate the need and nature for 
appropriate educational interventions to improve future antimicrobial utilisation in Zambia.  
 
Consequently, as a first step, this study explored physicians’ and pharmacists’ knowledge and 
perceptions regarding AMS at leading tertiary teaching hospitals in Zambia.  
 
Methods 
Study Design and Sites 
A cross-sectional study employing quantitative methods was undertaken.  
 
The University Teaching Hospitals (UTH) in Lusaka Zambia, were chosen for this initial study. This 
was because UTH are Zambia’s highest tertiary care referral public hospitals. They comprise a 
consortium of five specialised teaching hospitals namely: The Children’s hospital; Mother and New-
born hospital; Eye hospital; Adult hospital, and the Cancer Diseases hospital, respectively. The 
assumption was that if there were concerns regarding knowledge of AMS and AMR at this level of 
health care, these were likely to be greater at lower secondary care hospitals as well as primary 
healthcare centres in Zambia. 
 
Physicians and pharmacists practising at UTH were the population of interest as they are key health 
professionals directly involved in prescribing and dispensing antimicrobials in the hospitals. Moreover, 
by practising at the respective university teaching hospitals, they are also involved in teaching and 
mentoring undergraduate students, which are tomorrow’s health professionals.    
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Sample Size 
The sample size of physicians and pharmacists were independently determined using Yamane’s 
formula (67) where the total population of physicians at UTH stood at 210 and 85 pharmacists 
respectively at the time of the study. Using a confidence level of 95%, and a margin of error of 5%, 
the computed sample size was 137 physicians and 70 pharmacists, respectively.   
 
Data Collection and Instruments  
A structured self-administered questionnaire was used to collect data on the following aspects: (i) 
participants’ demographics; (ii) general knowledge on AMS; (iii) knowledge of the goals, objectives, 
and development strategies of AMS; (iv) perceptions and attitudes about antimicrobial utilisation and 
AMR; and (v) the perceived need for AMS training. The questionnaire was adapted from similar 
studies undertaken by Abbo and colleagues (68, 69). The questionnaire was piloted for consistency, 
length, and relevance of the questions among five physicians and five intern pharmacists at the Levy 
Mwanawasa Hospital in Lusaka during February 2017 and further refined. A total of 2007 
questionnaires were sent out and field data collection conducted from April to June 2017. 
 
Data Analysis 
Descriptive statistics were employed to analyse the data. Contingency tables were generated for 
frequencies and proportions of categorical variables. AMS knowledge scores were initially rated on a 
continuous scale out of 10. Subsequently, scores were categorized into three levels for ease of 
comparison and interpretation. These included: a 0 to 4 score as ‘low’, a 5 to 7 score as ‘moderate’ 
and an 8 to 10 score as ‘high’ knowledge level, respectively. Any associations between AMS 
knowledge and demographic variables were determined using the Freeman-Halton extension Fisher’s 
exact test. For statistical inference, a p-value of less than 0.05 was accepted as a statistically 
significant association. Likert scores for the perception data were summed and grouped into ‘agreed’, 
‘unsure’ and ‘disagreed’ categories, respectively. Numerical values of the 5-point Likert scale were 
grouped as follows: rating 1 and 2 = ‘disagreed’, 3 = ‘unsure’, and 4 and 5 = ‘agreed’. Depending on 
the nature of the statement asked, responses in agreement or disagreement were categorized as 
positive and negative perceptions accordingly. Stata 13 software (Stata Corp, College Station, TX, 
USA) was used for statistical analysis. 
 
Ethical Considerations 
Written informed consent was obtained from each participant prior to enrolment in the study. 
Completion of the questionnaires was anonymous and data confidentially maintained. The study 
posed no known risk to participants. Ethical approval for this study was obtained from the University 
of Zambia, School of Medicine Research Ethics Committee (IRB00001131 of IORG0000774). Formal 
permission to collect data was obtained from the hospital management at each respective site 
accordingly.    
 
Results 
Participants Demographics 
A total of 198 participants enrolled included, 137 physicians and 61  were pharmacists (95% response 
rate). Table 1 shows the demographic characteristics of the participants. 
 
INSERT TABLE 1 
 
Participants were mostly intern and resident physicians and pharmacists, and the majority of 
participants (55%) had less than five professional years of work experience (Table 1). There were a 
limited number of consultant-level physicians and clinical specialists in the sample, with few 
physicians (14%) and pharmacists having more than ten professional years of practice experience 
(14%). There was a relatively higher rate of refusal to participate in the study among senior ranked 
physicians and pharmacists than those in lower ranks. There were more participants from the Adult 
hospital which is currently the largest hospital among the UTH consortium and houses departments 
such as Internal Medicine, Surgery, Emergency and Critical Care, and the Adult Infectious Diseases 
Centre, respectively. 
 
Antimicrobial Stewardship knowledge  
Half (51%) of the physicians and 39% of the pharmacists indicated that they did not know what AMS 
was. Among those that indicated they knew what AMS was, only 9% of the physicians and 20% of the 
pharmacists demonstrated sufficient knowledge regarding the basic principles of AMS programmes. 
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Knowledge levels were significantly associated with practitioners’ years of professional practice, 
position, or practice rank, and having undertaken previous AMS training (Table 2).   
 
INSERT TABLE 2 
 
Perceptions of Antimicrobial Use and Antimicrobial resistance (AMR) 
Table 3 shows that the majority of participants had correct perceptions of and attitudes towards 
antimicrobial use and AMR in general. All participants (100%) agreed that inappropriate use of 
antimicrobials needs to be curbed, and the majority recognized AMR as a problem in their daily 
practice.    
 
INSERT TABLE 3 
 
Antimicrobial Stewardship training  
Only 8% of the 137 physicians surveyed indicated they had previously undertaken AMS training 
programmes elsewhere, whilst only 11% out of 61 pharmacists indicated similarly. Nearly all 
participants (98%) stated that they were not aware of any active AMS programmes in place at the 
hospital sites at the time of the survey. All participants (100%) agreed that there was a need for active 
and contextually-relevant AMS programmes and capacity-building at UTH. Table 4 shows the 
participants’ preferred modes of AMS training.  
 
INSERT TABLE 4 
 
Training workshops were the most preferred mode of AMS capacity building and professional 
development for the majority (>50%) of the participants, followed by on the job hands-on training. 
Short courses and self-paced online courses were least preferred (Table 4).   
 
Discussion 
This study explored physicians’ and pharmacists’ knowledge and perceptions of AMS at leading 
tertiary teaching hospitals in Zambia using a descriptive cross-sectional survey.  
 
Antimicrobial Stewardship knowledge levels as well as general knowledge on AMR 
We believe this is the first study to explore physicians’ and pharmacists’ knowledge and perceptions 
on AMS at leading university teaching hospitals in Zambia. Of concern was that this study found 
relatively low levels of conceptual knowledge on basic AMS principles and concepts assessed among 
physicians and pharmacists practicing at this consortium of leading referral teaching hospitals in 
Zambia. Overall, half (51%) of the physicians and 39% of the pharmacists at the teaching hospitals 
did not know about AMS (Table 2). It could be argued that these low levels of knowledge could be 
attributed to the fact that AMS was relatively a new concept coming to the fore in Zambia, which 
needs to be urgently addressed. 
 
Notwithstanding the generally low conceptual knowledge of AMS, encouragingly a much higher 
proportion of participants perceived that irrational antimicrobial use should be curbed, that it is a 
problem in their current practice, and they should consider sensitivity patterns when using 
antimicrobials (Table 3). This suggests that some aspects of AMS are informally known and practiced 
but perhaps not conceptually understood and formalised. Lack of or limited implementation of 
Antimicrobial Stewardship Programmes (ASPs) due to limited resources among tertiary hospitals (70), 
as recently evidenced in Nigeria (66), could also explain the existing knowledge gap among 
physicians and pharmacists in Zambia.  This is despite the concept of AMS programmes being an 
accepted global strategy to improve antimicrobial prescribing, especially in hospitals, to prevent AMR 
though recognising particular challenges in LMICs (39, 40, 71).  
 
Similarly, inadequate knowledge about rational antimicrobial use is an issue that has been identified 
in other LMICs. Donkor and colleagues found that just under half of the students at tertiary level 
facilities in Ghana had poor knowledge about the irrational use of antibiotics (72). A lack of knowledge 
of antibiotics and resistance was highlighted among pharmacy students and physicians in India and 
Pakistan, with the majority of physicians admitting to no training on rational antibiotic use (63, 73, 74). 
Similarly, there were concerns about the level of knowledge of antibiotics and AMR among medical 
students in South Africa (75) as well as appreciable differences in the knowledge and perception of 
AMS programmes among final year pharmacy students in South Africa (62). The majority of 
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physicians and nurses in Ethiopia also lack knowledge about antimicrobials and AMR (60), with 
physicians in Saudi Arabia believing education and adherence to guidelines can reduce AMR rates in 
hospitals (61). There have also been concerns regarding antibiotic prescribing and knowledge about 
AMR among physicians in tertiary facilities in Ghana and Nigeria, with prescribing influenced by 
pharmaceutical company representatives in Nigeria (46, 76). This contrasts with Namibia where the 
majority of antibiotic prescribing in hospitals complied with national guidelines, although lower than 
the target rate of 95% (30).  
 
The low levels of AMS knowledge in our study further highlight a gap that needs to be addressed 
through high impact educational interventions in the short-term among hospitals in Zambia as well as 
embedding AMS and associated programmes into health professionals’ education curricula both at 
undergraduate and postgraduate levels. Going forward, AMS needs to be a priority among health 
professional’s education programmes at all levels in Zambia as a sustainable measure given the 
current high rates of infectious diseases in Zambia. Burger and colleagues (62) in their study in South 
Africa also concluded that in order to help prevent AMR, efforts should be made to introduce concepts 
of AMS into the undergraduate pharmacy curricula to promote better use of antimicrobials and 
prevent AMR. This is being supported by newly developed guidelines on pharmacists’ roles in AMS 
programmes in South Africa (43).  
 
Whilst education is a pillar of any AMS strategy, we believe similarly to John and Fishman (77) that 
AMS educational programmes must be context specific and address local needs. This is important 
especially given the challenges of introducing AMS programmes among LMICs versus higher income 
countries, and reflects the complex nature of implementing AMS programmes in LMICs (40). There 
are also contextual variations regarding what constitutes an optimal educational programme on AMS 
in different country settings. For example, educational programmes on AMS can range from one-to-
one instructions to formal approaches including workshops, lectures, staff conferences, clinical 
pharmacy consultations, and drug utilisation evaluations (77).  
 
Our study revealed that the majority of physicians and pharmacists at UTH preferred formalized 
educational approaches such as structured training workshops on AMS whereas others preferred on 
the job hands-on training (Table 4). Further research is needed to explore how effective an 
educational intervention blending multidisciplinary learning through structured workshops, and on-the-
job hands-on training methods, will be to improve knowledge about AMS as well as improving 
antibiotic prescribing in Zambia. These are projects for the future.   
 
Perceptions of Antimicrobial Stewardship 
Encouragingly, the majority of physicians and pharmacists in this study appreciated the importance of 
rational antimicrobial use and AMR (Table 3). There was also no difference in perceptions among 
physicians and pharmacists. Our findings complement those of Abbo and colleagues (68), who found 
positive perceptions among nurse practitioners and physicians in Florida, USA, regarding antibiotics 
and AMR. Similarly, our study found that physicians and pharmacists at UTH in Zambia were aware 
of and concerned about irrational antimicrobial use. Most participants agreed that inappropriate use of 
antimicrobials needs to be curbed and that rational use of antimicrobials can prevent AMR (Table 3).  
 
There was however disagreement among some physicians and pharmacists on basing prescribing 
and the choice of antimicrobial on local antimicrobial policy and guidelines, which may reflect gaps in 
the levels of trust and confidence they have in existing policies and guidelines on antimicrobial use. 
This may also reflect a paramount need for health policymakers to regularly update and implement 
evidence-based antimicrobial policies and guidelines that health professionals will have confidence 
and trust adhering to. Trust in guidelines enhances their use (78).  
 
Recent evidence also suggests antibiotic decision-making is a social process dependent on cultural 
and contextual factors. Cultural boundaries in health care and across specialties still limits the 
involvement of allied health professionals in stewardship interventions (70), which needs to be 
addressed going forward. 
 
We believe the importance of such positive perceptions cannot be understated as behavioural 
changes among prescribers and dispensers of antimicrobials will be essential to enhance the prudent 
and rational use of antimicrobials in the future. Positive perceptions are essential to address variable 
adherence to guidelines and educational activities that currently exist across countries (30, 57, 79-
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83). As a result of our findings, we believe concerted efforts and educational strategies are needed at 
UTH to reduce the unjustified high rate of antimicrobial prescribing reported by Mudenda and 
colleagues (44). Undoubtedly, strengthening AMS practices through capacity-building is an urgent 
need in Zambia. The recognition of the importance of preventing AMR must be complemented by 
AMS programmes that enhance knowledge building about the extent of activities needed, and 
behavioural change strategies instigated, to ensure AMS programmes are effectively implemented 
starting in tertiary level teaching hospitals. These are programmes and research projects for the 
future. Overall, Zambia stands to benefit in reducing current AMR rates if capacity is built not only 
among prescribers and dispensers of antimicrobials but among all health professionals and the public 
in general.     
 
Implications for future policy and practice 
The low knowledge levels and positive views regarding AMS among physicians and pharmacists in 
Zambia needs to be further improved using locally-driven, context-specific and needs-based 
educational interventions. For example, educators of health professionals need to consider 
incorporating AMS in the undergraduate training programmes as well as introducing Continuous 
Professional Development programmes (CPD) for health professionals once qualified that can help 
build capacity. Leveraging educational opportunities to improve knowledge and practice of AMS 
among healthcare providers is a key strategy to reduce AMR in Zambia. Whereas previous and 
current local strategies in Zambia have largely focused on raising awareness on AMR (84), evidence-
based educational strategies to promote AMS practice and capacity have not yet been tried in 
Zambia.  
 
Generally, we believe there is an imminent need for policy and practice to prioritise AMS at health 
service delivery points in Zambia. Implementation of a national multi-sector action plan for AMR (84) 
by the government of Zambia demonstrates efforts being made towards addressing this need. 
Developing high coverage and high impact educational interventions using evidence-based behaviour 
change models alongside, as well as strengthening institutional frameworks and tools that enable 
effective implementation of AMS practices, can go a long way to enable health professionals to 
prudently and rationally utilize antimicrobials, thereby averting the spread of AMR in Zambia. 
Evidence shows that well implemented and targeted educational interventions are key to reducing 
AMR in LMICs (62). Further evidence suggests that if well designed and implemented, AMS 
strategies result in considerable benefits not only to the health system but also to patients (42). 
 
Limitations of the study 
We acknowledge that only physicians and pharmacists at the five specialized tertiary hospitals that 
constitute UTH were surveyed in this study. The study sample considered only a component of the 
professionals that make up the health workforce in Zambia. Though our findings may not be 
generalized to all health professionals throughout Zambia, we remain confident that the findings were 
likely to be similar in other local healthcare facilities. It will be interesting to monitor how AMS 
knowledge and perceptions of other health workers other than physicians and pharmacists compare. 
This is potentially future work.  
 
Due to limited resources, other tertiary teaching hospitals around Zambia were not surveyed. 
However, since the UTH represented the highest level of specialised tertiary care service delivery in 
Zambia’s healthcare system, and the facilities being public university teaching hospitals, our findings 
emphasising the urgency to address identified AMS knowledge and practice gaps should be 
applicable to other hospital settings in Zambia. Inherently, the cross-sectional study design was 
unable to establish temporality of knowledge and perception variables, and was unable to track 
relative changes in these and other parameters. Despite these limitations, we however believe our 
study findings provide valuable baseline data for future comparative, longitudinal and time-series 
evaluations. 
 
Conclusion 
 
Despite overall positive perceptions, there was relatively low conceptual knowledge of AMS among 
physicians and pharmacists at leading tertiary specialized teaching hospitals in Zambia. The majority 
of health professionals have not undertaken AMS training before. These knowledge gaps may 
significantly affect the prudent and rational antimicrobial utilization in Zambia enhancing AMR rates. 
There is an urgent need for AMS training and capacity-building to address knowledge and practice 
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gaps in Zambia if the country is to make positive strides in improving rational antimicrobial use among 
all health professionals. The findings from this study will be used to design appropriate interventions 
and initiatives to optimize future AMS programmes throughout Zambia to improve antimicrobial use. 
These interventions are starting to be implemented and will be followed up in the future. This may 
lead the way for other LMICs, with similar challenges.  
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Tables 
 
Table 1: Demographic characteristics of participants  
 
Characteristic Physicians (n, %) Pharmacists (n, %) 
Sex 
Male 
Female 
 
80 (58%) 
57 (42%) 
 
26 (43%) 
35 (57%) 
Years of Practice 
<5 years 
5 to 10 years 
>10 years 
 
81 (59%) 
37 (27%) 
19 (14%) 
 
28 (46%) 
24 (39%) 
  9 (15%) 
Position/Practice Rank 
Intern 
Resident 
Senior  
Consultant/Clinical Specialist 
 
58 (42%) 
55 (40%) 
10 (7%) 
14 (10%) 
 
28 (46%) 
21 (34%) 
 9 (15%) 
 3 (5%) 
Hospital 
Adult hospital 
Children’s hospital 
Mother and New-born hospital 
 
98 (71%) 
22 (16%) 
17 (12%) 
 
 
47 (77%)  
5 (8%) 
9 (15%) 
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Table 2: Physicians and pharmacists’ knowledge on AMS concepts 
 
Physicians Pharmacists 
AMS Knowledge 
None Moderate High None Moderate High 
Years of Practice 
≤5 years 56 (41%) 22 (16%) 3 (2%) 21 (34%) 17 (28%) 4 (7%) 
>5 years 14 (10%) 33 (24%) 9 (7%) 3 (5%) 8 (13%) 8 (13%) 
p < 0.0001**** p = 0.0042** 
Position/Practice Rank 
Junior Officer 
(Intern/Resident) 
68 (50%) 39 (28%) 6 (4%) 23 (38%) 19 (31%) 7 (11%) 
Senior Officer 
(Senior/Clinical 
Specialist) 
2 (1%) 16 (12%) 6 (4%) 1 (2%) 6 (10%) 5 (8%) 
p < 0.0001**** p = 0.018* 
Previous AMS training  
Have Ever 
Undertaken AMS 
Training 
0 (0%) 7 (5%) 4 (3%) 0 (0%) 4 (7%) 3 (5%) 
Never Undertaken 
AMS Training 
70 (51%) 48 (35%) 8 (6%) 24 (39%) 21 (34%) 9 (15%) 
p < 0.0001*** p = 0.029* 
*Freeman-Halton extension Fisher’s exact test  
 
Table 3: Participants’ perceptions and attitudes towards antimicrobial use and AMR  
Physicians (n, %) Pharmacists (n, %) 
Disagreed Unsure Agreed Disagreed Unsure Agreed 
Inappropriate use of antimicrobials 
needs to be curbed 
0 0 137 
(100%) 
0 0 61 
(100%) 
Antimicrobial resistance is 
currently NOT a problem in my 
daily practice 
129 
(94%) 
8 
(6%) 
0 59 
(97%) 
2 
(3%) 
0 
I consider microbial sensitivity 
patterns when selecting 
antimicrobials for treatment of a 
patient 
5 
(4%) 
17 
(12%) 
115 
(84%) 
2 
(3%) 
8 
(13%) 
51 
(84%) 
Rational use of antimicrobials can 
prevent antimicrobial resistance 
1 
(1%) 
3 
(2%) 
133 
(97%) 
4 
(7%) 
0 57 
(93%) 
Choice of antimicrobial use should 
be based on 
laboratory/microbiology test results 
15 
(11%) 
30 
(22%) 
92 
(67%) 
6 
(10%) 
8 
(13%) 
47 
(77%) 
Choice of antimicrobial to use 
must be based on hospital 
antimicrobial policy/guidelines 
17 
(12%) 
18 
(13%) 
102 
(74%) 
2 
(3%) 
4 
(7%) 
55 
(90%) 
Choice of antimicrobial to use 
should be based on antimicrobial 
medicines available in the 
Pharmacy 
16 
(12%) 
10 
(7%) 
111 
(81%) 
22 
(36%) 
7 
(11%) 
32 
(52%) 
Choice of antimicrobial used 
should be based on the severity of 
infection 
0 4 
(3%) 
133 
(97%) 
0 5 
(8%) 
56 
(92%) 
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Table 4: Participants’ preferred mode of AMS training 
Mode of AMS training preferred: Physicians (n = 137) Pharmacists (n = 61) 
Training workshops  51% 54% 
On the job hands-on training 24% 25% 
Short course (4 – 6 weeks) 11% 16% 
Self-paced online course 14% 5% 
  
 
 
 
 
